Iktos is a deep learning technology platform focused on new drug design and discovery.
Iktos has raised $2.6M in total funding. The most recent round was Grant. The last funding was announced in February 2025.
Iktos's investors include Bpifrance, Omnes Capital, EIC Accelerator, M Ventures, AGORANOV.
Iktos is headquartered in Paris, France.
Iktos is a deep learning technology platform focused on new drug design and discovery.
Iktos is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Iktos — Funding & Investors." VCBacked, February 20, 2025, https://www.vcbacked.co/company/iktos. Accessed July 20, 2026.
VCBacked. (2025). Iktos — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/iktos
{{cite web |title=Iktos — Funding & Investors |url=https://www.vcbacked.co/company/iktos |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated